Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary protein substrates in the GI tract are ingested proteins that are hydrolyzed by protease enzymes such as pepsin, trypsin, chymotrypsin, and carboxypeptidase during digestion[6][3][8]. These substrates are the starting materials for proteolysis, resulting in oligopeptides and free amino acids. The process involves a coordinated action of gastric, pancreatic, and microbial proteases, which enable absorption of amino acids for nutritional needs and metabolic functions. Dysregulation of protease activity, not of the substrate itself, is implicated in gastrointestinal disorders such as irritable bowel syndrome and inflammatory bowel disease[1][2][5]. This entry is a functional substrate category, not a molecular target (such as an enzyme or receptor), and should not be treated as a therapeutic target in pharmacological contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary protein substrate (hydrolyzed by intestinal proteases).